Lupin announced the launch of Leflunomide Tablets USP, 10 mg and 20 mg, having received an approval from the United States Food and Drug Administration (USFDA) earlier. The product would be manufactured at Lupin's Pithampur (Unit I) facility in India.
Lupin has received approval for its Leflunomide Tablets USP, 10 mg and 20 mg, from the United States Food and Drug Administration (U . S.)
Lupin Ltd`s Generic Leflunomide Receives Approval In US
Abhai`s Generic Leflunomide Receives Approval In US
Zydus Generic Leflunomide Receives Approval in US
Sanofi US announced today the availability of an authorized generic version of Arava®, Leflunomide tablets through Winthrop, the company's US generics division. For people living with rheumatoid arthritis (RA), Leflunomide blocks autoimmune antibodies that reduce inflammation with the aim of improving mobility. Sanofi's authorized generic version is the same formulation as the original drug, Arava, for which the company holds the original patent.
Sanofi US announced today the availability of an authorized generic version of Arava®, Leflunomide tablets through Winthrop, the company’s US generics division. For people living with rheumatoid arthritis (RA), Leflunomide blocks autoimmune antibodies that reduce inflammation with the aim of improving mobility. Sanofi’s authorized generic version is the same formulation as the original drug, Arava, for which the company holds the original patent.